ArticleFrontiers in oncology2019

WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling Cascade.

Shiu-Wen Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.